AU2017251691A1 — Methods of therapeutic monitoring of nitrogen scavenging drugs
Assigned to Horizon Therapeutics LLC · Expires 2017-11-09 · 9y expired
What this patent protects
METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitroge…
USPTO Abstract
METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders.
Drugs covered by this patent
- Ravicti (GLYCEROL PHENYLBUTYRATE) · Horizon Therap Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.